HealthEU-Startupsabout 2 hours ago
Immitra Bio raises €2.58 million pre-Seed
3 min read
Zürich-based Immitra Bio closed an upsized €2.58 million pre-Seed round for its scalable in-vivo genetic medicine platform. Backbone Ventures led the round, co-led by OCCIDENT, with participation from Another VC, Kickfund, Venture Kick, Zürcher Kantonalbank, FONGIT, ETH Foundation, and private investors. Non-dilutive funding contributed €161.8k.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
